Compare BCG & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCG | KYNB |
|---|---|---|
| Founded | 2016 | 1993 |
| Country | United States | United States |
| Employees | 150 | 34 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.4M | 27.1M |
| IPO Year | N/A | N/A |
| Metric | BCG | KYNB |
|---|---|---|
| Price | $1.54 | $7.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.7K | ★ 37.3K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $56.15 | ★ $0.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.36 | $6.32 |
| 52 Week High | $3.44 | $9.58 |
| Indicator | BCG | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 39.57 | 63.00 |
| Support Level | $1.50 | $6.59 |
| Resistance Level | $1.68 | $7.95 |
| Average True Range (ATR) | 0.08 | 0.32 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 20.01 | 72.73 |
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.